NY-22-0043
DE-22-0003-0
IN-22-0003
This amendment target zero cost sharing to individuals in any eligibility group who are eligible for extended postpartum coverage under section 1902(e)(16) of the Social Security Act.
State Email for 2021 BPD Data on 09/15/2022
Dear State Technical and Rebate Contacts,
This is a follow-up to the April 8, 2022 email reminder to states regarding preparation for the upcoming 2021 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
Manufacturer Email for 2021 BPD Data on 09/15/2022
Dear Manufacturer Technical and Invoice Contacts,
This is a follow-up to the April 8, 2022 email reminder to manufacturers regarding preparation for the upcoming 2021 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
State Email for 2021 BPD Data on 04/08/2022
Dear State Technical and Rebate Contacts,
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
Manufacturer Email for 2021 BPD Data on 04/08/2022
Dear Manufacturer Technical and Invoice Contacts,
Collections:
State Email for 2020 BPD Data on 08/15/2021
Dear State Technical and Rebate Contacts,
This is a follow-up to the April 26, 2021 email reminder to states regarding preparation for the upcoming 2020 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
Manufacturer Email for 2020 BPD Data on 08/15/2021
Dear Manufacturer Technical and Invoice Contacts,
This is a follow-up to the April 26, 2021 email reminder to manufacturers regarding preparation for the upcoming 2020 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections: